Alibaba Health Information Technology Ltd
Company Profile
Business description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Contact
Wangjing East Park
30th Floor, Greenland Center
Building 9, Zone 4
Chaoyang District
Beijing
CHNSector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 March 2026
Employees
1,364
Stocks News & Analysis
stocks
Our three most overvalued ASX shares
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,115.70 | 13.70 | -0.15% |
CAC 40 | 7,674.78 | 24.14 | -0.31% |
DAX 40 | 23,596.98 | 173.35 | -0.73% |
Dow JONES (US) | 45,400.86 | 220.43 | -0.48% |
FTSE 100 | 9,208.21 | 8.66 | -0.09% |
HKSE | 25,508.17 | 90.19 | 0.35% |
NASDAQ | 21,700.39 | 7.30 | -0.03% |
Nikkei 225 | 43,555.43 | 536.68 | 1.25% |
NZX 50 Index | 13,263.18 | 39.65 | 0.30% |
S&P 500 | 6,481.50 | 20.58 | -0.32% |
S&P/ASX 200 | 8,839.80 | 15.40 | -0.17% |
SSE Composite Index | 3,818.82 | 6.31 | 0.17% |